Eli Lilly and Co
Earnings playbook: Amazon and Alphabet headline the busiest week of the reporting period
Investors need to get ready for a deluge of corporate results this week. More than 110 companies in the S & P 500 are set to report, making it the busiest week of the fourth-quarter earnings season. Among the companies scheduled to post their latest financials are Amazon, Google-parent Alphabet and Disney. The season thus […]
Read More
Goldman says buy these five stocks ahead of earnings before it’s too late
Goldman Sachs says there’s still plenty of quality buying opportunities ahead of earnings. The Wall Street investment bank said companies such as Spotify are compelling, with more upside. Other buy-rated names screened by CNBC Pro include Eli Lilly, Roblox, Carlyle Group and On Holding. Carlyle Group Buy this cheap stock ahead of earnings, according to […]
Read More
Cramer’s week ahead: Earnings from Eli Lilly, Alphabet and Amazon. Plus, jobs data
The stock market is well-positioned to bounce next week if the heavyweight companies set to report earnings deliver strong numbers, CNBC’s Jim Cramer said Friday. That’s because the market ended the week on a subdued note, the “Mad Money” host said, after the S&P 500 finished in the red for three straight days. The busy […]
Read More
Eli Lilly CEO says Medicare coverage of obesity drugs could ‘change the game’ for upcoming pill launch
Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the rollout of the company’s closely watched experimental weight loss pill, orforglipron. In an exclusive interview with CNBC, Ricks said Lilly expects to have Medicare coverage for the treatment “immediately following that launch, and that […]
Read More
Eli Lilly plans $3.5 billion manufacturing plant in Pennsylvania to make next-generation obesity injections
Lilly Chair and CEO Dave Ricks speaks during a press conference for Eli Lilly and Company in Houston, Texas, U.S., Sept. 23, 2025. Antranik Tavitian | Reuters Eli Lilly on Friday said it will spend more than $3.5 billion to build a manufacturing plant in Lehigh Valley, Pennsylvania, that will help make its next-generation obesity […]
Read More
Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite
Drugmakers Roche and Sanofi’s latest earnings were largely as expected, with the companies talking up the potential of experimental medicines ahead of a looming “patent cliff” for Big Pharma. Both companies’ stocks were down less than 1% on Thursday after reporting earnings before the bell. They are both among the pharmaceutical companies that could see […]
Read More
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone. Top executives from drugmakers big and small told CNBC that the next phase […]
Read More
These 4 turnarounds are making headway – plus, updates on our 30 other stocks
Jim Cramer and Jeff Marks, the Club’s director of portfolio analysis, on Thursday delivered updates on all 34 Club holdings during the January Monthly Meeting. Here are the highlights from the first meeting of 2026, starting with our four turnaround stories: 4 turnaround plays Nike: The apparel and sneaker retailer has shown real signs of […]
Read More
The ‘sell America’ trade, Trump arrives in Davos, Netflix earnings and more in Morning Squawk
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Happy Wednesday. Or maybe not, if you held U.S. assets amid yesterday’s sell-off. S&P 500 futures are little changed this morning. The three major indexes are coming off their worst day in months. Here are five key things investors need to know […]
Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]
Read More